Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Postmenopausal Bone Loss With Nitric Oxide

NCT00043719 is registered in ClinicalTrials.gov with National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) as lead sponsor.

NCT NCT00043719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00043719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Postmenopausal Bone Loss With Nitric Oxide
Lead sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2002
Completion date
December 31, 2007
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteopenia, osteoporosis